These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37977771)

  • 21. Proliferating activity in differential diagnosis of benign phyllodes tumor and cellular fibroadenomas: is it helpful?
    Kaya R; Pestereli HE; Erdogan G; Gülkesen KH; Karaveli S
    Pathol Oncol Res; 2001; 7(3):213-6. PubMed ID: 11692149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates.
    Zhang Y; Kleer CG
    Arch Pathol Lab Med; 2016 Jul; 140(7):665-71. PubMed ID: 27362571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast.
    Feakins RM; Wells CA; Young KA; Sheaff MT
    Hum Pathol; 2000 Oct; 31(10):1214-22. PubMed ID: 11070114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Diagnostic Approach to Fibroepithelial Breast Lesions.
    Tan BY; Tan PH
    Surg Pathol Clin; 2018 Mar; 11(1):17-42. PubMed ID: 29413655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroepithelial lesions revisited: implications for diagnosis and management.
    Tan PH
    Mod Pathol; 2021 Jan; 34(Suppl 1):15-37. PubMed ID: 32461622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential cytologic features of fibroepithelial lesions of the breast.
    Deen SA; McKee GT; Kissin MW
    Diagn Cytopathol; 1999 Feb; 20(2):53-6. PubMed ID: 9951596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear survivin expression in stromal cells of phyllodes tumors and fibroadenomas of the breast.
    Hirano H; Matsushita K; Okimura A; Yoshida T; Kizaki T; Ito T
    Anticancer Res; 2014 Mar; 34(3):1251-3. PubMed ID: 24596368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in the Diagnosis of Phyllodes Tumors and Fibroadenomas Before and After Release of WHO Classification Standards.
    Chang J; Denham L; Dong EK; Malek K; Lum SS
    Ann Surg Oncol; 2018 Oct; 25(10):3088-3095. PubMed ID: 29987607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytological Criteria to Distinguish Phyllodes Tumour of the Breast from Fibroadenoma.
    Maritz RM; Michelow PM
    Acta Cytol; 2017; 61(6):418-424. PubMed ID: 28738381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of phyllodes breast tumors from fibroadenomas on MRI.
    Wurdinger S; Herzog AB; Fischer DR; Marx C; Raabe G; Schneider A; Kaiser WA
    AJR Am J Roentgenol; 2005 Nov; 185(5):1317-21. PubMed ID: 16247156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial intelligence modelling in differentiating core biopsies of fibroadenoma from phyllodes tumor.
    Cheng CL; Md Nasir ND; Ng GJZ; Chua KWJ; Li Y; Rodrigues J; Thike AA; Heng SY; Koh VCY; Lim JX; Hiew VJN; Shi R; Tan BY; Tay TKY; Ravi S; Ng KH; Oh KSL; Tan PH
    Lab Invest; 2022 Mar; 102(3):245-252. PubMed ID: 34819630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of fibroepithelial tumours of the breast.
    Badhe BA; Iyengar KR; Alva N
    Indian J Cancer; 2002; 39(3):91-6. PubMed ID: 12928563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression.
    Piscuoglio S; Ng CK; Murray M; Burke KA; Edelweiss M; Geyer FC; Macedo GS; Inagaki A; Papanastasiou AD; Martelotto LG; Marchio C; Lim RS; Ioris RA; Nahar PK; Bruijn ID; Smyth L; Akram M; Ross D; Petrini JH; Norton L; Solit DB; Baselga J; Brogi E; Ladanyi M; Weigelt B; Reis-Filho JS
    J Pathol; 2016 Mar; 238(4):508-18. PubMed ID: 26832993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms.
    Jara-Lazaro AR; Akhilesh M; Thike AA; Lui PC; Tse GM; Tan PH
    Histopathology; 2010 Aug; 57(2):220-32. PubMed ID: 20716164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors.
    Abe M; Miyata S; Nishimura S; Iijima K; Makita M; Akiyama F; Iwase T
    Breast Cancer; 2011 Oct; 18(4):268-72. PubMed ID: 22121516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Radiomics Approach for the Classification of Fibroepithelial Lesions on Breast Ultrasonography.
    Sim Y; Lee SE; Kim EK; Kim S
    Ultrasound Med Biol; 2020 May; 46(5):1133-1141. PubMed ID: 32102739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sonographic features of phyllodes tumors of the breast.
    Chao TC; Lo YF; Chen SC; Chen MF
    Ultrasound Obstet Gynecol; 2002 Jul; 20(1):64-71. PubMed ID: 12100421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation between phyllodes tumor and fibroadenoma using real-time elastography.
    Adamietz BR; Kahmann L; Fasching PA; Schulz-Wendtland R; Uder M; Beckmann MW; Meier-Meitinger M
    Ultraschall Med; 2011 Dec; 32 Suppl 2():E75-9. PubMed ID: 22194044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast.
    Resetkova E; Khazai L; Albarracin CT; Arribas E
    Breast J; 2010; 16(6):573-80. PubMed ID: 21070433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
    Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
    Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.